Compounds > 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and thiethylperazine

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with thiethylperazine in 1 studies

Compound Research Comparison

Studies
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Trials
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Recent Studies (post-2010)
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Studies
(thiethylperazine)		Trials
(thiethylperazine)		Recent Studies (post-2010) (thiethylperazine)
3304033206265

Protein Interaction Comparison

ProteinTaxonomy3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide (IC50)thiethylperazine (IC50)
Pleiotropic ABC efflux transporter of multiple drugsSaccharomyces cerevisiae S288C2.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Battistin, L; Briani, C; Cagnin, A; Chierichetti, F; Pizzolato, G; Tiberio, M1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and thiethylperazine

ArticleYear
Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade.
    European journal of neurology, 2004, Volume: 11, Issue:10

    Topics: Basal Ganglia; Benzamides; Brain Mapping; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine Isotopes; Middle Aged; Parkinsonian Disorders; Pyrrolidines; Thiethylperazine; Tomography, Emission-Computed, Single-Photon

2004